Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $3.26 million as of February 2, 2026. Its market cap has decreased by -94.07% in one year.

Market Cap

3.26M

Enterprise Value

n/a

Revenue

257.55M

Ranking

n/a

PE Ratio

0.27

Stock Price

$0.25

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from 39.11M to 3.26M, a decrease of -91.67%. That is a compound annual growth rate of -18.75%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	3.26M	-64.29%
Dec 31, 2025	9.12M	40.00%
Dec 31, 2024	6.51M	-90.41%
Dec 29, 2023	67.92M	-82.15%
Dec 30, 2022	380.45M	-42.14%
Dec 31, 2021	657.57M	8.37%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CTT Pharmaceutical Holdings	4.29M
Rafarma Pharmaceuticals	4.21M
Trees	3.81M
For The Earth	3.73M
Elixxer	3.19M
Indo Global Exchange(s) PTE	2.85M
Bespoke Extracts	2.81M
Panacea Life Sciences Holdings	2.65M

Market Cap Rankings